A team of Iranian researchers unveils the first meta-analysis on the dose-response association of aerobic exercise with weight, waist circumference and body fat in overweight and obese people.
Patients using icodec tend to have a higher incidence of hypoglycemic events compared to glargine or degludec, especially on days 2–4 of the weekly dosing cycle.